Literature DB >> 1357666

Somatostatin receptors are expressed by immature cerebellar granule cells: evidence for a direct inhibitory effect of somatostatin on neuroblast activity.

B Gonzalez1, P Leroux, M Lamacz, C Bodenant, R Balazs, H Vaudry.   

Abstract

Somatostatin and somatostatin receptors are transiently expressed in the immature rat cerebellar cortex but virtually undetectable in the cerebellum of adults. Although somatostatin binding sites have been visualized during the postnatal period in the external granule cell layer, the type of cell that expresses somatostatin receptors has never been identified; thus, the potential function of somatostatin in the developing cerebellum remains unknown. In the present study, we have taken advantage of the possibility of obtaining a culture preparation that is greatly enriched in immature cerebellar granule cells to investigate the presence of somatostatin receptors and the effect of somatostatin on intracellular messengers on cerebellar neuroblasts in primary culture. Autoradiographic labeling revealed the occurrence of a high density of binding sites for radioiodinated Tyr-[D-Trp8]somatostatin-(1-14) on 1-day-old cultured immature granule cells. Saturation and competition studies showed the existence of a single class of high-affinity binding sites (Kd = 0.133 +/- 0.013 nM, Bmax = 3038 +/- 217 sites per cell). Somatostatin induced a dose-dependent inhibition of forskolin-evoked cAMP formation (ED50 = 10 nM), and this effect was prevented by preincubation of cultured immature granule cells with pertussis toxin. Somatostatin also caused a marked reduction of intracellular calcium concentration. These results show the presence of functionally active somatostatin receptors on immature granule cells. Our data suggest the possible involvement of somatostatin in the regulation of proliferation and/or migration of neuroblasts during the development of the cerebellar cortex.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1357666      PMCID: PMC50185          DOI: 10.1073/pnas.89.20.9627

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents.

Authors:  C Kleuss; J Hescheler; C Ewel; W Rosenthal; G Schultz; B Wittig
Journal:  Nature       Date:  1991-09-05       Impact factor: 49.962

2.  Somatostatin-14 and somatostatin-28 induce opposite effects on potassium currents in rat neocortical neurons.

Authors:  H L Wang; C Bogen; T Reisine; M Dichter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

3.  Coincidence of EGF receptors and somatostatin receptors in meningiomas but inverse, differentiation-dependent relationship in glial tumors.

Authors:  J C Reubi; U Horisberger; W Lang; J W Koper; R Braakman; S W Lamberts
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

4.  Somatostatin expression in the cerebellar cortex during postnatal development. An immunohistochemical study in the rat.

Authors:  M J Villar; T Hökfelt; J C Brown
Journal:  Anat Embryol (Berl)       Date:  1989

5.  Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase.

Authors:  C Liebow; C Reilly; M Serrano; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

6.  Direct inhibitory effects of a somatostatin analog, SMS 201-995, on AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism.

Authors:  N Viguerie; N Tahiri-Jouti; A M Ayral; C Cambillau; J L Scemama; M J Bastié; S Knuhtsen; J P Estève; L Pradayrol; C Susini
Journal:  Endocrinology       Date:  1989-02       Impact factor: 4.736

7.  Somatostatin receptors: identification and characterization in rat brain membranes.

Authors:  C B Srikant; Y C Patel
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

8.  Somatostatin receptors in the human cerebellum during development.

Authors:  A Laquerrière; P Leroux; B Gonzalez; C Bodenant; J Tayot; H Vaudry
Journal:  Brain Res       Date:  1992-02-28       Impact factor: 3.252

9.  Pharmacological characterization of somatostatin receptors in the rat cerebellum during development.

Authors:  B J Gonzalez; P Leroux; C Bodenant; P Braquet; H Vaudry
Journal:  J Neurochem       Date:  1990-09       Impact factor: 5.372

10.  Block of calcium channels by enkephalin and somatostatin in neuroblastoma-glioma hybrid NG108-15 cells.

Authors:  A Tsunoo; M Yoshii; T Narahashi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

View more
  15 in total

Review 1.  The epidural and intrathecal administration of somatotrophin-release inhibiting factor: native and synthetic analogues.

Authors:  D P Beltrutti; S Moessinger; G Varrassi
Journal:  Curr Rev Pain       Date:  2000

Review 2.  Mechanisms of ischemic brain damage.

Authors:  Kristian P Doyle; Roger P Simon; Mary P Stenzel-Poore
Journal:  Neuropharmacology       Date:  2008-01-25       Impact factor: 5.250

3.  Occurrence of two somatostatin variants in the frog brain: characterization of the cDNAs, distribution of the mRNAs, and receptor-binding affinities of the peptides.

Authors:  H Tostivint; I Lihrmann; C Bucharles; D Vieau; Y Coulouarn; A Fournier; J M Conlon; H Vaudry
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

4.  Heteromultimerization of G-protein-gated inwardly rectifying K+ channel proteins GIRK1 and GIRK2 and their altered expression in weaver brain.

Authors:  Y J Liao; Y N Jan; L Y Jan
Journal:  J Neurosci       Date:  1996-11-15       Impact factor: 6.167

5.  Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development.

Authors:  D Vaudry; B J Gonzalez; M Basille; A Fournier; H Vaudry
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

6.  The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32.

Authors:  D Vaudry; B J Gonzalez; M Basille; T F Pamantung; M Fontaine; A Fournier; H Vaudry
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

7.  Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death.

Authors:  David Vaudry; Cécile Rousselle; Magali Basille; Anthony Falluel-Morel; Tommy F Pamantung; Marc Fontaine; Alain Fournier; Hubert Vaudry; Bruno J Gonzalez
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

8.  Pituitary adenylate cyclase-activating polypeptide prevents the effects of ceramides on migration, neurite outgrowth, and cytoskeleton remodeling.

Authors:  Anthony Falluel-Morel; David Vaudry; Nicolas Aubert; Ludovic Galas; Magalie Benard; Magali Basille; Marc Fontaine; Alain Fournier; Hubert Vaudry; Bruno J Gonzalez
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-04       Impact factor: 11.205

9.  A Peptidomic Approach to Characterize Peptides Involved in Cerebellar Cortex Development Leads to the Identification of the Neurotrophic Effects of Nociceptin.

Authors:  Auriane Corbière; Marie-Laure Walet-Balieu; Philippe Chan; Magali Basille-Dugay; Julie Hardouin; David Vaudry
Journal:  Mol Cell Proteomics       Date:  2018-06-12       Impact factor: 5.911

10.  Somatostatin and leu-enkephalin in the rat auditory brainstem during fetal and postnatal development.

Authors:  M Kungel; E Friauf
Journal:  Anat Embryol (Berl)       Date:  1995-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.